SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/CD4F91C755F55EEA32C4739E212387F8A8AAB14F13F45D75F5DD63EEE1BEAE2909B0307227255E41631BA7223BE98CEC>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/CD4F91C755F55EEA32C4739E212387F8A8AAB14F13F45D75F5DD63EEE1BEAE2909B0307227255E41631BA7223BE98CEC
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/CD4F91C755F55EEA32C4739E212387F8A8AAB14F13F45D75F5DD63EEE1BEAE2909B0307227255E41631BA7223BE98CEC
http://www.w3.org/2000/01/rdf-schema#comment
"high expression in high-grade bladder carcinoma cells makes IMP3 for an attractive target for therapy. The tumour promoting effect of IMP3 is independent from its regulatory action on IGF2 and CD44 expression"
xsd:string
http://purl.uniprot.org/uniprot/#_4D1344942E9835FECBAE4E23B1D50DEE6D4FA3887491FD6895979BE1B9193330A2FB88EB4D14B45D723A8CA02DE86EEB
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/CD4F91C755F55EEA32C4739E212387F8A8AAB14F13F45D75F5DD63EEE1BEAE2909B0307227255E41631BA7223BE98CEC
http://purl.uniprot.org/uniprot/B3KRZ1
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CD4F91C755F55EEA32C4739E212387F8A8AAB14F13F45D75F5DD63EEE1BEAE2909B0307227255E41631BA7223BE98CEC
http://purl.uniprot.org/uniprot/#_B3KRZ1-mappedCitation-22500655
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CD4F91C755F55EEA32C4739E212387F8A8AAB14F13F45D75F5DD63EEE1BEAE2909B0307227255E41631BA7223BE98CEC